{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T09:41:05Z","timestamp":1758102065780,"version":"3.44.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">IDH1<\/jats:italic> mutant prostatic adenocarcinoma represents a small fraction of prostate cancer with distinct epigenetic changes, characterized by genome-wide DNA hypermethylation. Recently, prostatic adenocarcinoma with intratumoral psammomatous calcifications was found to frequently harbors <jats:italic toggle=\"yes\">IDH1<\/jats:italic> R132 mutations. However, the association with <jats:italic toggle=\"yes\">IDH1<\/jats:italic> hotspot mutations and psammomatous calcifications in prostate cancer remains controversial. Here we report another rare case of <jats:italic toggle=\"yes\">IDH1<\/jats:italic> R132H mutant prostatic adenocarcinoma, showing intratumoral psammomatous calcifications identified in targeted needle biopsies as well as subsequent radical prostatectomy specimen. This case provides independent evidence for identification of <jats:italic toggle=\"yes\">IDH1<\/jats:italic> mutant prostate cancer by combined histologic features, including intratumoral psammomatous calcifications, anterior tumor location, and high Gleason score. In addition, to our knowledge, this is the first case of multifocal prostate cancer reported in the literature, with the co-existence of spatially disparate and genetically distinct tumor foci harboring <jats:italic toggle=\"yes\">IDH1<\/jats:italic> R132H mutation or <jats:italic toggle=\"yes\">TMPRSS2<\/jats:italic>-<jats:italic toggle=\"yes\">ERG<\/jats:italic> gene fusion in the same prostate.<\/jats:p>","DOI":"10.1097\/pas.0000000000002461","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T08:00:15Z","timestamp":1753776015000},"page":"1090-1096","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Psammomatous Calcifications Identified in Targeted Needle Biopsies and Radical Prostatectomy From IDH1 Mutant Prostatic Adenocarcinoma"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2787-3532","authenticated-orcid":false,"given":"Yang","family":"Zong","sequence":"first","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Sharobim","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Lawrence","sequence":"additional","affiliation":[{"name":"Radiology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[{"name":"Pathology and Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel D.","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"R1-20250917","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20250917","first-page":"10","article-title":"Cancer statistics","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"key":"R3-20250917","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"R4-20250917","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ng.2279","article-title":"Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer","volume":"44","author":"Barbieri","year":"2012","journal-title":"Nat Genet"},{"key":"R5-20250917","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41586-019-1318-9","article-title":"FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes","volume":"571","author":"Adams","year":"2019","journal-title":"Nature Jul"},{"key":"R6-20250917","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","journal-title":"Cell"},{"key":"R7-20250917","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nm0311-291","article-title":"Metabolism unhinged: IDH mutations in cancer","volume":"17","author":"Prensner","year":"2011","journal-title":"Nat Med"},{"key":"R8-20250917","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","article-title":"Biological role and therapeutic potential of IDH mutations in cancer","volume":"34","author":"Waitkus","year":"2018","journal-title":"Cancer Cell"},{"key":"R9-20250917","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1038\/onc.2011.546","article-title":"IDH mutation status in prostate cancer","volume":"31","author":"Ghiam","year":"2012","journal-title":"Oncogene"},{"key":"R10-20250917","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00345-018-2225-7","article-title":"Immunohistochemically detected IDH1(R132H) mutation is rare and mostly heterogeneous in prostate cancer","volume":"36","author":"Hinsch","year":"2018","journal-title":"World J Urol"},{"key":"R11-20250917","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neo.2017.12.001","article-title":"IDH1R132H promotes malignant transformation of benign prostatic epithelium by dysregulating microRNAs: involvement of IGF1R-AKT\/STAT3 signaling pathway","volume":"20","author":"Zhang","year":"2018","journal-title":"Neoplasia"},{"key":"R12-20250917","doi-asserted-by":"crossref","first-page":"100616","DOI":"10.1016\/j.modpat.2024.100616","article-title":"Histopathologic and molecular characterization of IDH-mutant prostatic adenocarcinoma","volume":"38","author":"Samueli","year":"2025","journal-title":"Mod Pathol"},{"key":"R13-20250917","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/PAI.0b013e3182649d1c","article-title":"Immunohistochemical demonstration of isocitrate dehydrogenase 1 (IDH1) mutation in a small subset of prostatic carcinomas","volume":"22","author":"Mauzo","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R14-20250917","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.24379","article-title":"Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers","volume":"125","author":"Kang","year":"2009","journal-title":"Int J Cancer"},{"key":"R15-20250917","doi-asserted-by":"crossref","first-page":"100146","DOI":"10.1016\/j.modpat.2023.100146","article-title":"Highly recurrent IDH1 mutations in prostate cancer with psammomatous calcification","volume":"36","author":"Mehra","year":"2023","journal-title":"Mod Pathol"},{"key":"R16-20250917","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pathol.2023.06.017","article-title":"IDH1 p.R132C mutation in prostatic carcinoma with psammomatous calcifications: report of two cases","volume":"56","author":"Galea","year":"2024","journal-title":"Pathology"},{"key":"R17-20250917","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","article-title":"Monoclonal antibody specific for IDH1 R132H mutation","volume":"118","author":"Capper","year":"2009","journal-title":"Acta Neuropathol"},{"key":"R18-20250917","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1750-3639.2009.00352.x","article-title":"Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors","volume":"20","author":"Capper","year":"2010","journal-title":"Brain Pathol"},{"key":"R19-20250917","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.cell.2018.10.019","article-title":"Genomic hallmarks and structural variation in metastatic prostate cancer","volume":"175","author":"Quigley","year":"2018","journal-title":"Cell"},{"key":"R20-20250917","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1593\/neo.10726","article-title":"Antibody-based detection of ERG rearrangement-positive prostate cancer","volume":"12","author":"Park","year":"2010","journal-title":"Neoplasia"},{"key":"R21-20250917","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/PAS.0b013e31821e8761","article-title":"Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas","volume":"35","author":"Chaux","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R22-20250917","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.eururo.2016.07.008","article-title":"Intratumoral and intertumoral genomic heterogeneity of multifocal localized prostate cancer impacts molecular classifications and genomic prognosticators","volume":"71","author":"Wei","year":"2017","journal-title":"Eur Urol"},{"issue":"Suppl 1","key":"R23-20250917","first-page":"S13","article-title":"The evolving landscape of prostate cancer somatic mutations","volume":"82 Suppl 1","author":"Cotter","year":"2022","journal-title":"Prostate"},{"key":"R24-20250917","first-page":"152","article-title":"Distribution and significance of microcalcifications in the neoplastic and nonneoplastic prostate","volume":"122","author":"Woods","year":"1998","journal-title":"Arch Pathol Lab Med"},{"key":"R25-20250917","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.anndiagpath.2007.07.001","article-title":"Calcifications in prostate and ejaculatory system: a study on 298 consecutive whole mount sections of prostate from radical prostatectomy or cystoprostatectomy specimens","volume":"12","author":"Suh","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"R26-20250917","doi-asserted-by":"crossref","first-page":"101516","DOI":"10.1016\/j.molmet.2022.101516","article-title":"Multiple metabolic pathways fuel the truncated tricarboxylic acid cycle of the prostate to sustain constant citrate production and secretion","volume":"62","author":"Fregeau-Proulx","year":"2022","journal-title":"Mol Metab"},{"key":"R27-20250917","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/1878-0261.13441","article-title":"Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle that can be targeted for therapeutic purposes in prostate cancer","volume":"17","author":"Gonthier","year":"2023","journal-title":"Mol Oncol"},{"key":"R28-20250917","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.juro.2006.07.054","article-title":"Citrate concentrations in human seminal fluid and expressed prostatic fluid determined via 1H nuclear magnetic resonance spectroscopy outperform prostate specific antigen in prostate cancer detection","volume":"176","author":"Kline","year":"2006","journal-title":"J Urol"},{"key":"R29-20250917","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature19062","article-title":"Molecular modifiers reveal a mechanism of pathological crystal growth inhibition","volume":"536","author":"Chung","year":"2016","journal-title":"Nature Aug"},{"key":"R30-20250917","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s11427-013-4522-0","article-title":"The molecular basis for ethnic variation and histological subtype differences in prostate cancer","volume":"56","author":"Zong","year":"2013","journal-title":"Sci China Life Sci"},{"key":"R31-20250917","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/cbin.12000","article-title":"Determination of TMPRSS2-ERG, SPOP, FOXA1, and IDH1 prostate cancer molecular subtypes in Colombian patients and their possible implications for prognosis","volume":"47","author":"Montero-Ovalle","year":"2023","journal-title":"Cell Biol Int"},{"key":"R32-20250917","doi-asserted-by":"crossref","DOI":"10.1007\/s10528-024-10974-4","article-title":"Prevalence of SPOP and IDH gene mutations in prostate cancer in a Jordanian population","author":"Alorjani","year":"2024","journal-title":"Biochem Genet"},{"key":"R33-20250917","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/pros.23830","article-title":"SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer","volume":"79","author":"Hernandez-Llodra","year":"2019","journal-title":"Prostate"},{"key":"R34-20250917","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat Genet"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:00:23Z","timestamp":1758085223000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002461"}},"subtitle":["Case Report and Literature Review"],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002461","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"type":"print","value":"0147-5185"},{"type":"electronic","value":"1532-0979"}],"subject":[],"published":{"date-parts":[[2025,7,29]]}}}